{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:05:54Z","timestamp":1791965154215,"version":"4.3.4"},"reference-count":98,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1498,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1365-2036.2011.04783.x","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T01:02:06Z","timestamp":1311728526000},"page":"702-713","source":"Crossref","is-referenced-by-count":71,"title":["Systematic review: the pathophysiology and management of polycystic liver disease"],"prefix":"10.1111","volume":"34","author":[{"given":"F.","family":"Temmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Missiaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Laleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cassiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Verslype","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van Pelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,26]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1478-3231.2007.01595.x","article-title":"Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease","volume":"28","author":"Hoevenaren","year":"2008","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jlts.2001.22178","article-title":"Liver transplantation for polycystic liver disease","volume":"7","author":"Pirenne","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.3748\/wjg.v13.i38.5052","article-title":"Surgical management of polycystic liver disease","volume":"13","author":"Russel","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1538\/expanim.49.51","article-title":"Characterization of a novel polycystic kidney rat model with accompanying polycystic liver","volume":"49","author":"Katsuyama","year":"2000","journal-title":"Exp Anim"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1523-1755.2001.00473.x","article-title":"The PCK rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease","volume":"59","author":"Lager","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"C1205","DOI":"10.1152\/ajpcell.00313.2002","article-title":"Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes","volume":"284","author":"Gong","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032,5\u2032-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e328328f4ff","article-title":"Cholangiociliopathies: genetics, molecular mechanisms and potential therapies","volume":"25","author":"Masyuk","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2353\/ajpath.2008.080125","article-title":"Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease","volume":"173","author":"Banales","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1104","article-title":"Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease","volume":"33","author":"Drenth","year":"2003","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.1840400404","article-title":"Polycystic disease of the liver","volume":"40","author":"Everson","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-0004.2009.01353.x","article-title":"Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63","volume":"78","author":"Waanders","year":"2010","journal-title":"Clin Genet"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3\u2003years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1523-1755.2005.00201.x","article-title":"Molecular pathogenesis of ADPKD: the polycystin complex gets complex","volume":"67","author":"Ong","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbadis.2007.01.003","article-title":"TRPP2 and autosomal dominant polycystic kidney disease","volume":"1772","author":"Kottgen","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0092-8674(00)81793-6","article-title":"The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I","volume":"87","author":"Qian","year":"1996","journal-title":"Cell"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1097-2765(00)80135-5","article-title":"Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease","volume":"2","author":"Watnick","year":"1998","journal-title":"Mol Cell"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/75981","article-title":"Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations","volume":"25","author":"Watnick","year":"2000","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-8417-2-6","article-title":"Emerging evidence of a link between the polycystins and the mTOR pathways","volume":"2","author":"Boletta","year":"2009","journal-title":"Pathogenetics"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4065\/73.1.80","article-title":"Ludwig symposium on biliary disorders - part I. Pathogenesis of ductal plate abnormalities","volume":"3","author":"Desmet","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB25|cit25","first-page":"180","article-title":"The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis","volume":"114","author":"Ramos","year":"1990","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2003.50006","article-title":"Clinical profile of autosomal dominant polycystic liver disease","volume":"37","author":"Qian","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.1840110406","article-title":"Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin","volume":"11","author":"Everson","year":"1990","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB29|cit29","first-page":"G335","article-title":"Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium","volume":"269","author":"Perrone","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"C1748","DOI":"10.1152\/ajpcell.1997.272.5.C1748","article-title":"Autosomal dominant polycystic kidney disease decreases anion exchanger activity","volume":"272","author":"Perrone","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.1840400413","article-title":"Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid","volume":"40","author":"Nichols","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000163955","article-title":"Primary cilia in normal and pathological tissues","volume":"63","author":"Wheatley","year":"1995","journal-title":"Pathobiology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0140-6736(03)12662-1","article-title":"Polycystic kidney disease - the ciliary connection","volume":"361","author":"Ong","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.physiol.67.040403.101353","article-title":"A physiological view of the primary cilium","volume":"67","author":"Praetorius","year":"2005","journal-title":"Annu Rev Physiol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"F1159","DOI":"10.1152\/ajprenal.00118.2005","article-title":"An incredible decade for the primary cilium: a look at a once-forgotten organelle","volume":"289","author":"Davenport","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/dvdy.21530","article-title":"Cholangiocyte primary cilia in liver health and disease","volume":"237","author":"Masyuk","year":"2008","journal-title":"Dev Dyn"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2353\/ajpath.2008.070293","article-title":"Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney","volume":"172","author":"Alvaro","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.gastro.2006.07.023","article-title":"Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver","volume":"132","author":"Alvaro","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-8278(00)80377-3","article-title":"Regulation and deregulation of cholangiocyte proliferation","volume":"33","author":"Alvaro","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/modpathol.2008.115","article-title":"Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease","volume":"21","author":"Waanders","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/03008209609028882","article-title":"Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic kidney disease","volume":"33","author":"Murray","year":"1996","journal-title":"Connect Tissue Res"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hep.21143","article-title":"Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases","volume":"43","author":"Fabris","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"C419","DOI":"10.1152\/ajpcell.00038.2007","article-title":"VEGF receptor inhibition blocks liver cysts growth in pkd2(WS25\/-) mice","volume":"293","author":"Amura","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1445-2197.1996.tb01148.x","article-title":"Hepatic cystic disease in an adult polycystic kidney disease transplant population","volume":"66","author":"Harris","year":"1996","journal-title":"Aust N Z J Surg"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB45|cit45","first-page":"1282","article-title":"Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease","volume":"26","author":"Sherstha","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.3748\/wjg.v12.i22.3537","article-title":"Estrogens and the pathophysiology of the biliary tree","volume":"12","author":"Alvaro","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1478-3231.2010.02247.x","article-title":"Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases","volume":"31","author":"Van Keimpema","year":"2011","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/hmg\/ddp463","article-title":"PRKCSH\/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2\/TRPP2 against HERP-mediated degradation","volume":"19","author":"Gao","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1074\/jbc.M805828200","article-title":"80K-H interacts with inositol 1,4,5-trisphosphate (IP3) receptors and regulates IP3-induced calcium release activity","volume":"284","author":"Kawaai","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0016-5085(03)01201-0","article-title":"Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis","volume":"125","author":"Shibao","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/jhep.2000.8265","article-title":"Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B\/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, (Ca2+)-, and protein kinase C alpha-dependent mechanisms","volume":"32","author":"Glaser","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.22636","article-title":"The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)","volume":"49","author":"Banales","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","article-title":"Sirolimus reduces polycystic liver volume in ADPKD patients","volume":"19","author":"Qian","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/hep.23511","article-title":"Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice","volume":"51","author":"Spirli","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0272-6386(12)80923-1","article-title":"Hepatic cysts in autosomal dominant polycystic kidney disease","volume":"22","author":"Everson","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): magnetic Resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide","volume":"5","author":"Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/hep.24036","article-title":"Medical and surgical treatment options for polycystic liver disease","volume":"52","author":"Drenth","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1155\/1996\/83547","article-title":"Obstructive jaundice associated with polycystic liver disease","volume":"10","author":"Dmitrewski","year":"1996","journal-title":"HPB Surg"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF01655097","article-title":"Infection of hepatic cysts in polycystic disease","volume":"8","author":"Abascal","year":"1984","journal-title":"World J Surg"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3171\/jns.1998.89.5.0719","article-title":"Screening for intracranial aneurysms in patients with isolated polycystic liver disease","volume":"89","author":"Schievink","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"b3763","DOI":"10.1136\/bmj.b3763","article-title":"Screening for intracranial aneurysms in ADPKD","volume":"339","author":"Ong","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/ajkd.2001.29216","article-title":"Mitral valve prolaps and mitral regurgitation are common in patients with polycystic kidney disease type I","volume":"38","author":"Lumiaho","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2214\/ajr.145.2.229","article-title":"Liver cysts in autosomal-dominant polycystic kidney disease: clinical and computed tomographic study","volume":"145","author":"Levine","year":"1985","journal-title":"Am J Roentgenol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2214\/ajr.164.2.7839965","article-title":"Hepatobiliary cysts in patients with autosomal dominant polycystic kidney disease: prevalence and CT findings","volume":"164","author":"Itai","year":"1995","journal-title":"Am J Roentgenol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1097-0096(200007\/08)28:6<277::AID-JCU2>3.0.CO;2-L","article-title":"Abdominal sonographic study of autosomal dominant polycystic kidney disease","volume":"28","author":"Nicolau","year":"2000","journal-title":"J Clin Ultrasound"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.1840080626","article-title":"Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts","volume":"8","author":"Everson","year":"1988","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1478-3231.2009.02055.x","article-title":"Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease","volume":"29","author":"Waanders","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/STROKEAHA.110.578740","article-title":"Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease","volume":"42","author":"Xu","year":"2011","journal-title":"Stroke"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.ackd.2009.12.005","article-title":"Isolated polycystic liver disease","volume":"17","author":"Qian","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2009.13","article-title":"Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease","volume":"5","author":"Ecder","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13651820410023950","article-title":"Laparoscopic management of benign liver diseases: where are we?","volume":"6","author":"Gigot","year":"2004","journal-title":"HPB"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2214\/ajr.141.3.559","article-title":"Percutaneous aspiration of hepatic cysts does not provide definitive therapy","volume":"141","author":"Saini","year":"1983","journal-title":"Am J Roentgenol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2214\/ajr.144.2.237","article-title":"Hepatic cysts: treatment with alcohol","volume":"1","author":"Bean","year":"1985","journal-title":"Am J Roentgenol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11605-007-0376-8","article-title":"Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%","volume":"12","author":"van Keimpema","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/bjs.1800710331","article-title":"Partial resection and fenestration in the treatment of polycystic liver disease","volume":"71","author":"Armitage","year":"1984","journal-title":"Br J Surg"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/gut.2004.046524","article-title":"The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection","volume":"54","author":"Schindl","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB82|cit82","unstructured":"http:\/\/www.eltr.org"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1753-4887.2007.00005.x","article-title":"Role of nutrition in liver transplantation for end-stage chronic liver disease","volume":"66","author":"Stickel","year":"2008","journal-title":"Nutr Rev"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/lt.20979","article-title":"Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula","volume":"12","author":"Freeman","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/lt.20974","article-title":"Model for end-stage liver disease (MELD) exception for polycystic liver disease","volume":"12","author":"Arrazola","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00007890-199503270-00025","article-title":"Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival","volume":"59","author":"Rasmussen","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.2007.03067.x","article-title":"A 12-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly","volume":"68","author":"Andries","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2036.2011.04783.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0168-8278(10)60068-2","article-title":"Growth of liver volume stops after one year of lanreotide in patients with polycystic livers","volume":"52","author":"Chrispijn","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMe1006925","article-title":"mTOR inhibitors in polycystic kidney disease","volume":"363","author":"Watnick","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ndt\/gfq384","article-title":"Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats","volume":"26","author":"Renken","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ackd.2010.01.006","article-title":"Treatment strategies and clinical trial design in ADPKD","volume":"17","author":"Torres","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/j.ajkd.2010.11.029","article-title":"Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study","volume":"57","author":"Torres","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1365-2036.2011.04783.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.2011.119","article-title":"Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease","volume":"80","author":"Irazabal","year":"2011","journal-title":"Kidney Int"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04783.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04783.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T21:20:45Z","timestamp":1625433645000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2011.04783.x"}},"subtitle":["Systematic review: pathophysiology and management of polycystic liver disease"],"short-title":[],"issued":{"date-parts":[[2011,7,26]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04783.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,26]]}}}